NCT03015168View on ClinicalTrials.gov

Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Rectal CancerPrognosis
Interventions
RADIATION

capecitabine and concurrent intensity modulated radiotherapy

patients with rectal cancer undergoing capecitabine and concurrent intensity modulated radiotherapy

Trial Locations (1)

750004

General Hospital of Ningxia Medical University, Yinchuan

All Listed Sponsors
lead

General Hospital of Ningxia Medical University

OTHER

NCT03015168 - Prognostic Value of Neutrophil-to-lymphocyte Ratio (NLR) on Rectal Cancer Patients | Biotech Hunter | Biotech Hunter